Nano3D Biosciences (n3D) is a biotechnology startup based in Houston, TX, established in 2008. The company specializes in 3D cell culture solutions for various biomedical applications such as research, drug discovery, toxicology, precision medicine, and regenerative medicine. n3D's proprietary technology, magnetic 3D bioprinting, involves magnetizing cells and using magnetic forces to aggregate them into models that mimic native tissue environments. The company's platform offers significant advantages in terms of speed, ease, and handling compared to other 3D cell culture and bioprinting platforms. n3D has built a global presence through its worldwide distribution network and has established an OEM partnership with Greiner Bio-One. Despite details about the last investment and investors not being available, the company's unique technology and its applications in critical sectors make it an intriguing prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Nano3D Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
